References

1. Canavan, M.M., 1931, Schilder's encephalitis periaxialis diffusa. Arch. Neurol. Psychiatry 25, 299-308.

2. van Bogaert, L., and Bertrand, I., 1949, Su une idiotie familiale avec degenerescence spongieuse de neuraxe (note preliminaire), Acta. Neurol. Belg. 49, 572-587.

3. Matalon, R., Michals, K., Sebesta, D., Deanching, M., Gashkoff, P., and Casanova, J., 1988,

Aspartoacylase deficiency and N-acetyl-aspartic aciduria in patients with Canavan disease, Am. J. Med. Genet. 29, 463-471.

4. Birnbaum, S.M., Levinton, L., Kingsley, R.B., and Greenstei, J.P., 1952, Specificity of aminoacid acylases, J. Biol. Chem. 194, 455-462.

5. Matalon, R.M., Michals-Matalon-K., 2000, Spongy degeneration of the brain, Canavan disease :

biochemical and molecular findings, FrontBiosci, Mar 1 :5 :D307-11.

6. Globus, J.H. and Strauss, I., 1928, Progressive degenerative subcortical encephalopathy (Schilder's disease), Arch. Neurol. Psychiatry 20, 1190-1228.

7. Adachi, M., Torii, J., Schneck, L., and Volk, B.W., 1972, Electron microscopic and enzyme histochemical studies of the cerebellum in spongy degeneration (van Bogaert and Bertrand type), Acta Neuropathol. (Berl) 20, 22-31.

8. Adornato, B.T., O'Brien, J.S., Lampert, P.W., Roe, T.F., and Neustein, H.B., 1972, Cerebral spongy degeneration of infancy: a biochemical and ultrastructural study of affected twins, Neurology 22, 202210.

9. Kaul, R., Balamurugan, K., Gao, G.P., and Matalon, R., 1994a, Canavan disease: genomic organization and localization of human ASPA to 17p13-ter: conservation of the ASPA gene during evolution, Genomics 21, 364-370.

10. Banker, B.Q.,. and Victor, H., 1979, Spongy degeneration of infancy, in: Genetic diseases among

Ashkenazi Jews, R.M. Goodman., and A.G. Motulsky., Eds., Raven Press, New York, pp. 201-217.

11. Matalon, R., and Michals-matalon, K., 2000, Spongy degeneration of the brain, Canavan disease:

biochemical and molecular findings, Front. Biosci. D, 307-311.

12. Matalon, R., Michals-Matalon, K, 1998, Molecular: basis of Canavan disease, Eur J Paediatr Neurol.

13. Ozand, P.T.; Gascon, G., and Dhalla, M., 1990, Aspartoacylase deficiency and Canavan disease in Saudi

14. Matalon, R., Michals-Matalon, K., 1999, Recent advances in Canavan disease, Adv. Pediatr. 46, 493-506.

15. Matalon, R., Matalon, K.M., 2002, Canavan disease prenatal diagnosis and genetic counseling, Obstet

Gynecoi Clin North Am. Jun:29(2):297-304.

16. Matalon, R., Kaul, R., Casanova, J., Michals, K., Johnson, A., Rapin, I., Gashkoff, P., and Deanching, M.,

1989, Aspartoacylase deficiency: the enzyme defect in Canavan disease, J. Inherit. Metab. Dis. 12, 329-331.

17. Zeng,B.J., Wang,Z.H., Ribeiro,L.A., Leone,P., De Gasperi, R., Kim, S.J., Raghavan,S., Ong,E.,

Pastores,G.M., Kohodny,E.H., 2002, Identification and characterization of novel mutations of the Aspartoacylase gene in non-Jewish patients with Canavan disease, J Inherit.Metab. Dis., Nov:25(7):557-570.

18. Shaag, A., Anikster, Y., Christensen, E., Glustein, J.Z., Fois, A., Michelakakis, H., Nigro, F., Pronicka, E.,

Ribes, A., Zabot, M.T., Elpeleg, O.N., 1995, The molecular basis of Canavan (aspartoacylase deficiency) disease in European non-Jewish patients, Am. J. Hum. Genet. 57, 572-580.

19. Olsen, T.R., Tranebjaerg, L., Kvittingen, E.A., Hagenfeldt, L., Moller, C., and Nilssen, O., 2002, Two novel aspartoacylase (ASPA) gene missense missense mutations specific to Norweigian and Swedish patient with Canavan disease, J. Med. Genet. 39, e55.

20. Bluml, S., Seymour, K., Philippart, M., Matalon, R., and Ross, B., 1998, Elevated brain water in Canavan disease: impact of a diuretic therapy, Proceeding of the 6th International Society for Magnetic Resonance in Medicine, P 171.

21. Leone, P., Janson, CG., Bilaniuk, L, Wang, Z., Sorgi, F., Huang, L., Matalon, R., Kaul, R., Seng, Z.,

Freese, A., McPhee, S.W., Mee, E., During, MJ.,2000, Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Ann: Neurol. Jul;48(1):27-38.

22. Kaul, R., Gao, G.P., Balamurugan, K. and Matalon, R., 1993, Human aspartoacylase cDNA and mis-sense mutation in Canavan disease, Nat. Genet. 5, 118-123.

23. Kaul, R., Gao, G.P., Aloya, M., Balamurugan, K., Petrosky, A., Michals, K., and Matalon, R., 1994b,

Canavan disease: Mutations among non-Jewish patients, Am. J. Hum. Genet. 55, 34-41.

24. Kaul, R., Gao, G.P., Michals, K., Whelan, D.T., Levin, S. and Matalon, R., 1995, Novel (cys 125 arg)

missense mutation in an Arab patient with Canavan disease, Hum. Mutat. 5, 269-271.

25. Kaul, R., Gao, G.P., Matalon, R., Aloya, M., Su, M., Jin, M., Johnson, A.B., Shutgens, R.B. and Clarke,

J.T., 1996, Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease, Am. J. Hum. Genet. 59, 95-102.

26. Matalon, R., Kaul, R. and Michals, K, 1994, Carrier rate of Canavan disease among Ashkenazi Jewish individuals, Am. J. Hum. Genet. 55, A157.

27. Kronn, D., Oddoux, C., Phillips, J. and Ostrer, H., 1995, Prevalence of Canavan disease heterozygous in the New York metropolitan Ashkenazi Jewish individuals, Am. J. Hum. Genet. 57, 1250-1252.

28. Alford, R.L., DeMarchi, J.M., and Richards, C.S., 1998, Frequency of a DNA polymorphism at position

Y231 in the aspartoacylase gene and its impact on DNA-based carrier testing for Canavan disease in Ashkenazi Jewish population, Hum. Mutat. (suppl. 1), S161-162. 29 Propheta, O., Magal, N., Shohat, M., Eyal, N., Navot, N. and Horowitz, M., 1998, A benign polymorphism in the aspartoacylase gene may cause misrepresentation of Canavan gene testing, Eur. J. Hum. Genet. 6, 635-637.

30. Surendran, S., Bamforth, F.J., Chan, A.,Tyring, S.K., Goodman, S.I., and Mataon, R.,2003a, Mild elevation of N-acetyl aspartic acid, macrocephaly: diagnostic problem for Canavan disease, J. Child Neurol. 18, 809-812..

31. Baslow, M.H., Suckow, R., Sapirstein, V., and Hungund, B.L., 1999, Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes, J.Mol. Neurosci. 13, 47-53.

32. Surendran, S., Matalon, K.M., Szucs, S., Tyring, S.K., Matalon, R., 2003 Metabolic changes in the knockout muse for Canavan's disease implications for patients with Canavan's disease, J Child Neurol, Sep: 18(9):611-5.

33. Goldstein, F.B., 1969, The enzymatic synthesis of N-cetyl-L-aspartic acid by subcellular preparations of the rat brain, J. Biol. Chem. 244, 4257-4260.

34. Birken, D.L., and Olendroff, W.H., 1989, N-acetyl-Laspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain, Neurosci. Behav. Rev. 13, 23-31.

35. Jacobson, K.B., 1957, Studies on the role of N-acetylaspartic acid in mammalian brain, J. Gene Physiol.

36. Tallan, H.H., Moore, S., and Stein, W.H., 1956, N-acetyl-L-aspartic acid in brain, J. Biol. Chem. 219,

Was this article helpful?

0 0

Post a comment